|Articles|March 1, 2004
- BioPharm International-03-01-2004
- Volume 17
- Issue 3
Tefen Operations Excellence
On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.
Advertisement
On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.
For more information about the consortium and details on future meetings please e-mail us at
Articles in this issue
almost 22 years ago
Qualifying Release Laboratories in Europe and the United Statesalmost 22 years ago
Operations Excellence: BioPharma Consortium Discusses Key Industry Trendsalmost 22 years ago
Keeping Biopharmaceutical Cleanrooms Compliantalmost 22 years ago
Site Expansion - Regional Roundup: Pennsylvaniaalmost 22 years ago
Site Expansion - Regional Roundup: Delawarealmost 22 years ago
Final Word: Beware of Patent Infringement During Discovery Researchalmost 22 years ago
StreetTalk: It Takes Two (Or Does It?)Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
4
Navigating the Next Wave of Biopharma Manufacturing Innovation
5
